Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Neurobiol Dis ; 98: 36-51, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27890673

RESUMO

ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease. Although ABHD12 is suspected to play a role in the lysophosphatidylserine and/or endocannabinoid pathways, its precise functional role(s) leading to PHARC disease had not previously been characterized. Cell and zebrafish models were designed to demonstrate the causal link between an identified new missense mutation p.T253R, characterized in ABHD12 from a young patient, the previously characterized p.T202I and p.R352* mutations, and the associated PHARC. Measuring ABHD12 monoacylglycerol lipase activity in transfected HEK293 cells demonstrated inhibition with mutated isoforms. Both the expression pattern of zebrafish abhd12 and the phenotype of specific antisense morpholino oligonucleotide gene knockdown morphants were consistent with human PHARC hallmarks. High abhd12 transcript levels were found in the optic tectum and tract, colocalized with myelin basic protein, and in the spinal cord. Morphants have myelination defects and concomitant functional deficits, characterized by progressive ataxia and motor skill impairment. A disruption of retina architecture and retinotectal projections was observed, together with an inhibition of lens clarification and a low number of mechanosensory hair cells in the inner ear and lateral line system. The severe phenotypes in abhd12 knockdown morphants were rescued by introducing wild-type human ABHD12 mRNA, but not by mutation-harboring mRNAs. Zebrafish may provide a suitable vertebrate model for ABHD12 insufficiency and the study of functional impairment and potential therapeutic rescue of this rare, neurodegenerative disease.


Assuntos
Ataxia/genética , Catarata/genética , Monoacilglicerol Lipases/genética , Mutação de Sentido Incorreto , Polineuropatias/genética , Retinose Pigmentar/genética , Adulto , Animais , Animais Geneticamente Modificados , Ataxia/patologia , Ataxia/fisiopatologia , Catarata/patologia , Catarata/fisiopatologia , Feminino , Expressão Gênica , Técnicas de Silenciamento de Genes , Células HEK293 , Humanos , Modelos Animais , Monoacilglicerol Lipases/metabolismo , Bainha de Mielina/metabolismo , Bainha de Mielina/patologia , Fenótipo , Polineuropatias/patologia , Polineuropatias/fisiopatologia , RNA Mensageiro/metabolismo , Retinose Pigmentar/patologia , Retinose Pigmentar/fisiopatologia , Sensação/fisiologia , Natação/fisiologia , Peixe-Zebra
2.
Int J Cardiol ; 249: 340-343, 2017 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-28986054

RESUMO

Hemodynamic forces have been known for a long time to regulate cardiogenic processes such as cardiac valve development. During embryonic development in vertebrates, the outflow tract (OFT) adjacent to the ventricle comes under increasing hemodynamic load as cardiogenesis proceeds. Consequently, extracellular matrix components are produced in this region as the cardiac cushions form which will eventually give rise to the aortic valves. The proteoglycan AGGRECAN is a key component of the aortic valves and is frequently found to be deregulated in a variety of aortic valve diseases. Here we demonstrate that aggrecan expression in the OFT of developing zebrafish embryos is hemodynamically dependent, a process presumably mediated by mechanosensitive channels. Furthermore, knockdown or knockout of aggrecan leads to failure of the OFT to develop resulting in stenosis. Based on these findings we analysed the expression of AGGRECAN in human bicuspid aortic valves (BAV). We found that in type 0 BAV there was a significant reduction in the expression of AGGRECAN. Our data indicate that aggrecan is required for OFT development and when its expression is reduced this is associated with BAV in humans.


Assuntos
Agrecanas/biossíntese , Valva Aórtica/anormalidades , Cardiopatias Congênitas/metabolismo , Doenças das Valvas Cardíacas/embriologia , Doenças das Valvas Cardíacas/metabolismo , Ventrículos do Coração/embriologia , Ventrículos do Coração/metabolismo , Adulto , Agrecanas/genética , Animais , Valva Aórtica/embriologia , Valva Aórtica/crescimento & desenvolvimento , Valva Aórtica/metabolismo , Doença da Válvula Aórtica Bicúspide , Expressão Gênica , Cardiopatias Congênitas/genética , Doenças das Valvas Cardíacas/genética , Ventrículos do Coração/crescimento & desenvolvimento , Humanos , Peixe-Zebra
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA